SHL Telemedicine logo

SHLTN - SHL Telemedicine Share Price

CHF5.95 0.0  0.0%

Last Trade - 09/07/20

Sector
Healthcare
Size
Small Cap
Market Cap £52.6m
Enterprise Value £57.5m
Revenue £33.2m
Position in Universe 770th / 1039
Bullish
Bearish
Unlock SHLTN Revenue
Momentum
Relative Strength (%)
1m -0.25%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
40.0 37.1 40.5 37.4 48.9 41.9 +0.9%
-62.9 +10,686 -40.2
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, SHL Telemedicine Ltd revenues decreased 14% to $41.9M. Net income decreased 44% to $5.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Depreciation and amortization increase from $220K to $452K (expense), Selling and marketing expenses increase of 7% to $2.8M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SHLTN Revenue Unlock SHLTN Revenue

Net Income

SHLTN Net Income Unlock SHLTN Revenue

Normalised EPS

SHLTN Normalised EPS Unlock SHLTN Revenue

PE Ratio Range

SHLTN PE Ratio Range Unlock SHLTN Revenue

Dividend Yield Range

SHLTN Dividend Yield Range Unlock SHLTN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SHLTN EPS Forecasts Unlock SHLTN Revenue
Profile Summary

SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Public Since November 15, 2000
No. of Shareholders: n/a
No. of Employees: 448
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange SIX Swiss Exchange
Shares in Issue 10,503,152
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SHLTN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SHLTN
Upcoming Events for SHLTN
Thursday 1st October, 2020
SHL Telemedicine Ltd Annual Shareholders Meeting
Frequently Asked Questions for SHL Telemedicine
What is the SHL Telemedicine share price?

As of 09/07/20, shares in SHL Telemedicine are trading at CHF5.95, giving the company a market capitalisation of £52.6m. This share price information is delayed by 15 minutes.

How has the SHL Telemedicine share price performed this year?

Shares in SHL Telemedicine are currently trading at CHF5.95 and the price has moved by -7.75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the SHL Telemedicine price has moved by -0.91% over the past year.

What are the analyst and broker recommendations for SHL Telemedicine?

Of the analysts with advisory recommendations for SHL Telemedicine, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for SHL Telemedicine is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will SHL Telemedicine next release its financial results?

SHL Telemedicine is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the SHL Telemedicine dividend yield?

SHL Telemedicine does not currently pay a dividend.

Does SHL Telemedicine pay a dividend?

SHL Telemedicine does not currently pay a dividend.

When does SHL Telemedicine next pay dividends?

SHL Telemedicine does not currently pay a dividend.

How do I buy SHL Telemedicine shares?

To buy shares in SHL Telemedicine you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of SHL Telemedicine?

Shares in SHL Telemedicine are currently trading at CHF5.95, giving the company a market capitalisation of £52.6m.

Where are SHL Telemedicine shares listed? Where are SHL Telemedicine shares listed?

Here are the trading details for SHL Telemedicine:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: SHLTN
What kind of share is SHL Telemedicine?

Based on an overall assessment of its quality, value and momentum, SHL Telemedicine is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a SHL Telemedicine share price forecast 2020?

Shares in SHL Telemedicine are currently priced at CHF5.95. At that level they are trading at 76.47% discount to the analyst consensus target price of 0.00.

How can I tell whether the SHL Telemedicine share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SHL Telemedicine. Over the past six months, the relative strength of its shares against the market has been 19.42%. At the current price of CHF5.95, shares in SHL Telemedicine are trading at -1.45% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the SHL Telemedicine PE Ratio?

The SHL Telemedicine PE ratio based on its reported earnings over the past 12 months is 11.2. The shares are currently trading at CHF5.95.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of SHL Telemedicine?

SHL Telemedicine's management team is headed by:

Ralf Bork - OTH
Yoav Rubinstein - CEO
Yariv Alroy - CHM
Yossi Vadnagra - CFO
Yoni Dagan - CTO
Eran Kristal - OTH
Yehoshua Abramovich - DRC
Erez Alroy - NED
Amir Lerman - NED
Yi He - NED
Hava Shechter - NED
Who are the major shareholders of SHL Telemedicine?

Here are the top five shareholders of SHL Telemedicine based on the size of their shareholding:

Mengke (Cai) & Shen (Kun) Individual Investor
Percentage owned: 54.87% (5.97m shares)
Alroy Group Corporation
Percentage owned: 23.05% (2.51m shares)
Carthy (Ziv) Individual Investor
Percentage owned: 8.47% (922k shares)
Schroder ISF Sustainable Swiss Equity Mutual Fund
Percentage owned: 0.22% (24.0k shares)
Schroder Investment Management (Switzerland) AG Investment Advisor
Percentage owned: 0.22% (24.0k shares)
Similar to SHLTN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.